IP Verse

Pharmathen competitive analysis

Loading summary...

Latest oppositions filed by Pharmathen

Explore patent oppositions filed by Pharmathen against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 30, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP2959894	S1P Receptor Modulators For Treating Multiple Sclerosis	NOVARTIS	Oct 12, 2022

Latest patents of Pharmathen opposed by its competitors

Explore Pharmathen's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 30, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP3010962	Feb 8, 2023	Preparation Of Polylactide-Polyglycolide Microparticles Having A Sigmoidal Release Profile	1

Latest publications and patents of Pharmathen New

Explore the latest publications and patents granted to Pharmathen, showcasing their recent innovations and technological advancements.

Last updated on: Oct 23, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Pharmathen
EP3010962	Feb 8, 2023	Preparation Of Polylactide-Polyglycolide Microparticles Having A Sigmoidal Release Profile	Patent Maintained As Amended

Latest PTAB cases involving Pharmathen

Discover the latest PTAB cases involving Pharmathen, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Pharmathen with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 30, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
PHARMATHEN	1	1	-	-
ALKERMES PHARMA IRELAND	6	9	1	2
NOVARTIS	6	422	-	21